Stay updated on Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6 on the page, indicating a small backend/software patch rather than a content change.
    Difference
    0.0%
    Check dated 2026-09-01T20:39:46.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A funding line noting the U.S. NIH Grant/Contract was added to the study record. This reflects government support for the trial.
    Difference
    0.0%
    Check dated 2026-08-25T20:44:24.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.4 to v3.6.5, indicating a new document version. This update reflects versioning only and does not change the page content or functionality.
    Difference
    0.0%
    Check dated 2026-08-11T15:42:18.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Removed the Plain Language Summary from the Study Details page, eliminating the plain-language overview of the trial’s purpose and design.
    Difference
    0.0%
    Check dated 2026-08-04T09:19:40.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    A new 2026 publication entry is added to the Publications section, noting a 5-year extended follow-up of KEYNOTE-590 in the Japanese subgroup. The earlier 'Online ahead of print' citation is removed and the page revision is updated to v3.6.4.
    Difference
    0.0%
    Check dated 2026-07-28T05:49:10.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Adds a new bibliographic citation for a 2026 article on quality-adjusted survival in pembrolizumab plus chemotherapy for advanced esophageal cancer to the Publications section, and updates the page’s revision history from 3.6.2 to 3.6.3.
    Difference
    0.0%
    Check dated 2026-07-06T15:48:55.000Z thumbnail image

Stay in the know with updates to Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.